You are here > News and publications

News and publications

Promethera Biosciences to be present at J.P. Morgan Healthcare Conference 2016

05/01/2016

Promethera Biosciences will be participating to the 34th edition of the annual J.P. Morgan Healthcare Conference which will be held from 11 to 15 January 2016 in San Francisco.

 

The J.P. Morgan Healthcare conference is the biggest healthcare investment event and attracts a broad range of analysts and institutional investors.

 

John Tchelingerian - CEO, and Frank Hazevoets - CFO and Head Corporate Development - will be present to meet with investors and potential partners and share with them Promethera's strategic vision for future developments.

Contacts

PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
B-1435 Mont-Saint-Guibert
(Belgium)
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01

News and Public release

CEO John Tchelingerian to Discuss Strategic Collobarations and Partnering Strategies in Cell Therapy at ARM’s Advanced Therapies Summit
Collaboration to Drive Development and Commercialization of Promethera’s Cell-based Liver-Focused Therapeutics Portfolio in Korea